durvalumab
astrazeneca
['bcsm', 'durvalumab', 'tnbc']
. will present "clinical outcomes and immune markers by race in a phase i/ii clinical trial of durvalumab concomitant with neoadjuvant chemotherapy in early-stage #tnbc" at 1:15pmcdt #asco22 in hall b. #bcsm 
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.